CYCC - Cyclacel Pharmaceuticals - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

with an average price target of $-2566.88. This is a potential upside of $-2573.25 (-40396.39%) from yesterday's end of day stock price of $6.37.

Cyclacel Pharmaceuticals's activity chart (see below) currently has 12 price targets and 11 ratings on display.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 100% with an average time for these price targets to be met of 307.25 days.

Most recent stock forecast was given by JONATHAN ASCHOFF from ROTH MKM on 03-May-2024. First documented stock forecast 27-Apr-2020.

Best performing analysts who are covering CYCC - Cyclacel Pharmaceuticals:

Kevin Degeeter Jonathan Aschoff James Edwardes Jones Kumaraguru Raja

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy

$176

$169.63 (2662.95%)

$336

1 years 5 months 6 days ago
(03-May-2024)

3/3 (100%)

$-51.63 (-22.68%)

60

Buy

$8

$5.1 (175.86%)

$10

2 years 4 months 15 days ago
(25-May-2023)

3/3 (100%)

$-2.05 (-20.40%)

30

Buy

$5280

2 years 7 months 2 days ago
(07-Mar-2023)

1/1 (100%)

$-2180.71 (-29.23%)

615

Buy

$4080

3 years 2 months 21 days ago
(18-Jul-2022)

2/2 (100%)

$-8058.6 (-66.39%)

524

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is CYCC (Cyclacel Pharmaceuticals) average time for price targets to be met?

On average it took 307.25 days on average for the stock forecasts to be realized with a an average price target met ratio 100

Which analyst has the current highest performing score on CYCC (Cyclacel Pharmaceuticals) with a proven track record?

KEVIN DEGEETER

Which analyst has the current lower performing score on CYCC (Cyclacel Pharmaceuticals) with a proven track record?

KUMARAGURU RAJA

Which analyst has the most public recommendations on CYCC (Cyclacel Pharmaceuticals)?

Kevin Degeeter works at LADENBURG and has 4 price targets and 3 ratings on CYCC

Which analyst is the currently most bullish on CYCC (Cyclacel Pharmaceuticals)?

Jonathan Aschoff with highest potential upside - $169.63

Which analyst is the currently most reserved on CYCC (Cyclacel Pharmaceuticals)?

Kevin Degeeter with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?